<DOC>
	<DOCNO>NCT00009646</DOCNO>
	<brief_summary>This trial determine whether give low-dose indomethacin infant weight 500 999 gram ( approximately 1 2 pound ) birth improve survival without cerebral palsy developmental problem 18 22 month age .</brief_summary>
	<brief_title>Trial Indomethacin Prophylaxis Preterm Infants ( TIPP )</brief_title>
	<detailed_description>Prophylactic indomethacin reduces patent ductus arteriosus ( PDA ) intraventricular hemorrhage low birth weight infant . However , effect early indomethacin long-term neurodevelopment remain uncertain . There also insufficient evidence rule serious adverse effect , increase risk necrotizing enterocolitis ( NEC ) retinopathy prematurity ( ROP ) . The aim trial determine prophylactic administration indomethacin improve survival without neurosensory impairment extremely-low-birth-weight infant . Infants ( n=1202 ) birthweights 500 999 gram randomize 2 6 hour birth receive either intravenous indomethacin ( 0.1 mg/kg ) equal volume normal saline placebo , daily 3 day . The primary outcome correct age 18 month composite death , cerebral palsy , cognitive delay , deafness , blindness . Secondary long-term outcome hydrocephalus necessitating placement shunt , seizure disorder , microcephaly . Secondary short-term outcome patent ductus arteriosus , pulmonary hemorrhage , chronic lung disease , cranial ultrasonographic abnormality , nectrotizing enterocolitis retinopathy . Infants evaluate follow-up 18-22 month correct age .</detailed_description>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>Birth weight 500 999 gram ; Postnatal age great 2 hour ; Unable administer study drug within 6 hour birth ; Structural heart disease and/or renal disease ; Dysmorphic feature congenital abnormality ; Tocolytic therapy indomethacin prostaglandin inhibitor within 72 hour prior delivery ; Overt clinical bleed one site ; Platelet count le 50 x 109/L ; Hydrops ; Not consider viable</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Hours</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Chronic lung disease</keyword>
	<keyword>Indocin</keyword>
	<keyword>Indomethacin</keyword>
	<keyword>Infants , low birth weight</keyword>
	<keyword>Intraventricular hemorrhage</keyword>
	<keyword>Necrotizing enterocolitis</keyword>
	<keyword>Patent ductus arteriosus</keyword>
	<keyword>Pulmonary hemorrhage</keyword>
</DOC>